novo nordisk semaglutide vial FDA Approval Expands Nordisk's Wegovy to the Fatty Liver Disease MASH Injection FDA approves Lilly's Foundayo Size:3mL* 50 vials

novo nordisk semaglutide vial FDA Approval Expands Nordisk's Wegovy to the Fatty Liver Disease MASH Injection FDA approves Lilly's Foundayo Size:3mL* 50 vials

FDA approves Lilly's Foundayo (orforglipron) GLP-1 pill for weight loss

Meanwhile, individuals who took a high-potency GLP-1 drug approved for obesity — such as semaglutide (Wegovy ® ), which is now more commonly used to treat the condition — had greater persistence at 14% three years after initiating therapy

Injection

Size:3mL* 50 vials

Still, the Black Box warning remains: If you have a family history of endocrine tumors or medullary thyroid cancer, these drugs are not for you